← runs
AAPL
Apple Inc.live runfigures
| field | value | statement row | printed |
|---|---|---|---|
| Total revenue | $478.8B | R5 Total net sales | 478,834 millions |
| Operating income | $158.1B | R15 Operating income | 158,063 millions |
| Net income attributable to the company | $132.2B | R19 Net income | 132,175 millions |
| Diluted EPS | $8.98 | R22 Diluted | 8.98 |
| Cash and cash equivalents | $36.3B | R3 Cash and cash equivalents | 36,305 millions |
| Total assets | $404.5B | R16 Total assets | 404,548 millions |
| Total liabilities | $292.5B | R29 Total liabilities | 292,455 millions |
| Total shareholders' equity attributable to the company | $112.1B | R35 Total shareholders’ equity | 112,093 millions |
| Net cash from operating activities | $145.1B | R16 Cash generated by operating activities | 145,097 millions |
| Net cash from investing activities | -$17.3B | R23 Cash generated by/(used in) investing activities | (17,280) millions |
| Net cash from financing activities | -$127.4B | R32 Cash used in financing activities | (127,446) millions |
checks
- assets = liabilities + equity · total assets equals total liabilities and equity
- equity excludes minority interests · not applicable: no noncontrolling interest line printed
- net income is before preferred dividends · net income is not the after-preferred-dividends line
- diluted EPS is for total net income · diluted EPS is for total net income
- net income excludes minority interests · not applicable: no noncontrolling interest line printed
- cash flows tie to the change in cash · not applicable: missing a section total or no net change in cash line
management's claims
No year-over-year claims about the headline figures were found in management's discussion.
restatements vs the 2025 10-K
All 11 of last year's figures are reprinted exactly as the 2025 10-K first reported them. Nothing was restated.
trace
0locator (code)1.02s
{ "tables": 60, "exhibits": [], "documents": 1 }{ "income": { "rows": 26, "scale": 1000000, "score": 49.75, "heading": "STATEMENTS OF OPERATIONS (In millions, except number of shares, which are reflected in thousands, and per-share amounts)", "tableIndex": 14, "runnerUpScore": 24.25 }, "balance": { "rows": 37, "scale": 1000000, "score": 52, "heading": "Inc. CONSOLIDATED BALANCE SHEETS (In millions, except number of shares, which are reflected in thousands, and par value)", "tableIndex": 16, "runnerUpScore": 14.25 }, "cashflow": { "rows": 35, "scale": 1000000, "score": 52, "heading": "ed Financial Statements. Apple Inc. | 2026 Form 10-K | 35 Apple Inc. CONSOLIDATED STATEMENTS OF CASH FLOWS (In millions)", "tableIndex": 18, "runnerUpScore": 7 } }1income statement agent3.00s · 1450 tokens · $0.0002
{ "rows": 26, "retryHint": null, "tableIndex": 14 }{ "figures": [ { "note": "Total net sales is the company-wide revenue total.", "field": "revenue", "scale": 1000000, "value": 478834000000, "printed": "478,834", "rowIndex": 5, "rowLabel": "Total net sales", "priorValue": 416161000000, "agentPrinted": "478,834", "failedChecks": [], "priorPrinted": "416,161", "groundingMismatch": false }, { "note": "This row explicitly reports operating income.", "field": "operatingIncome", "scale": 1000000, "value": 158063000000, "printed": "158,063", "rowIndex": 15, "rowLabel": "Operating income", "priorValue": 133050000000, "agentPrinted": "158,063", "failedChecks": [], "priorPrinted": "133,050", "groundingMismatch": false }, { "note": "This is the only net income line printed.", "field": "netIncome", "scale": 1000000, "value": 132175000000, "printed": "132,175", "rowIndex": 19, "rowLabel": "Net income", "priorValue": 112010000000, "agentPrinted": "132,175", "failedChecks": [], "priorPrinted": "112,010", "groundingMismatch": false }, { "note": "This row reports diluted earnings per share.", "field": "epsDiluted", "scale": 1, "value": 8.98, "printed": "8.98", "rowIndex": 22, "rowLabel": "Diluted", "priorValue": 7.46, "agentPrinted": "8.98", "failedChecks": [], "priorPrinted": "7.46", "groundingMismatch": false } ], "statement": "income", "tableIndex": 14, "priorColumn": 1, "currentColumn": 0 }2balance sheet agent3.10s · 1369 tokens · $0.0002
{ "rows": 37, "retryHint": null, "tableIndex": 16 }{ "figures": [ { "note": "This is the balance sheet's cash and cash equivalents line.", "field": "cash", "scale": 1000000, "value": 36305000000, "printed": "36,305", "rowIndex": 3, "rowLabel": "Cash and cash equivalents", "priorValue": 35934000000, "agentPrinted": "36,305", "failedChecks": [], "priorPrinted": "35,934", "groundingMismatch": false }, { "note": "This row explicitly prints total assets.", "field": "totalAssets", "scale": 1000000, "value": 404548000000, "printed": "404,548", "rowIndex": 16, "rowLabel": "Total assets", "priorValue": 359241000000, "agentPrinted": "404,548", "failedChecks": [], "priorPrinted": "359,241", "groundingMismatch": false }, { "note": "This is the standalone total liabilities line, not total liabilities and equity.", "field": "totalLiabilities", "scale": 1000000, "value": 292455000000, "printed": "292,455", "rowIndex": 29, "rowLabel": "Total liabilities", "priorValue": 285508000000, "agentPrinted": "292,455", "failedChecks": [], "priorPrinted": "285,508", "groundingMismatch": false }, { "note": "This is the shareholders’ equity total, with no noncontrolling interests shown.", "field": "totalEquity", "scale": 1000000, "value": 112093000000, "printed": "112,093", "rowIndex": 35, "rowLabel": "Total shareholders’ equity", "priorValue": 73733000000, "agentPrinted": "112,093", "failedChecks": [], "priorPrinted": "73,733", "groundingMismatch": false } ], "statement": "balance", "tableIndex": 16, "priorColumn": 1, "currentColumn": 0 }3cash flow agent3.19s · 1457 tokens · $0.0002
{ "rows": 35, "retryHint": null, "tableIndex": 18 }{ "figures": [ { "note": "This is the operating-activities total after changes in operating assets and liabilities.", "field": "operatingCashFlow", "scale": 1000000, "value": 145097000000, "printed": "145,097", "rowIndex": 16, "rowLabel": "Cash generated by operating activities", "priorValue": 111482000000, "agentPrinted": "145,097", "failedChecks": [], "priorPrinted": "111,482", "groundingMismatch": false }, { "note": "This row reports the total cash used in investing activities.", "field": "investingCashFlow", "scale": 1000000, "value": -17280000000, "printed": "(17,280)", "rowIndex": 23, "rowLabel": "Cash generated by/(used in) investing activities", "priorValue": 15195000000, "agentPrinted": "(17,280)", "failedChecks": [], "priorPrinted": "15,195", "groundingMismatch": false }, { "note": "This row reports the total cash used in financing activities.", "field": "financingCashFlow", "scale": 1000000, "value": -127446000000, "printed": "(127,446)", "rowIndex": 32, "rowLabel": "Cash used in financing activities", "priorValue": -120686000000, "agentPrinted": "(127,446)", "failedChecks": [], "priorPrinted": "(120,686)", "groundingMismatch": false } ], "statement": "cashflow", "tableIndex": 18, "priorColumn": 1, "currentColumn": 0 }4reconciler (code)0.00s
null
[ { "name": "balance_identity", "detail": "total assets equals total liabilities and equity", "fields": [ "totalAssets" ], "passed": true, "skipped": false, "statement": "balance" }, { "name": "totalEquity_attribution", "detail": "no noncontrolling interest line printed", "fields": [ "totalEquity" ], "passed": true, "skipped": true, "statement": "balance" }, { "name": "netIncome_before_preferred", "detail": "net income is not the after-preferred-dividends line", "fields": [ "netIncome" ], "passed": true, "skipped": false, "statement": "income" }, { "name": "epsDiluted_total", "detail": "diluted EPS is for total net income", "fields": [ "epsDiluted" ], "passed": true, "skipped": false, "statement": "income" }, { "name": "netIncome_attribution", "detail": "no noncontrolling interest line printed", "fields": [ "netIncome" ], "passed": true, "skipped": true, "statement": "income" }, { "name": "cash_flow_tie", "detail": "missing a section total or no net change in cash line", "fields": [ "operatingCashFlow", "investingCashFlow", "financingCashFlow" ], "passed": true, "skipped": true, "statement": "cashflow" } ]5MD&A claims agent1.13s · 607 tokens · $0.0001
null
[]
6restatement check (code)3.92s
{ "priorRunId": "08efe430-1f77-40da-9b75-8d32e3c7571a", "priorPeriodEnd": "2025-09-27", "priorAccessionNumber": "0000320193-25-000079" }[ { "pct": 0, "delta": 0, "field": "revenue", "revised": false, "original": 416161000000, "realigned": false, "reprinted": 416161000000, "originalRow": "Total net sales", "reprintedRow": "Total net sales" }, { "pct": 0, "delta": 0, "field": "operatingIncome", "revised": false, "original": 133050000000, "realigned": false, "reprinted": 133050000000, "originalRow": "Operating income", "reprintedRow": "Operating income" }, { "pct": 0, "delta": 0, "field": "netIncome", "revised": false, "original": 112010000000, "realigned": false, "reprinted": 112010000000, "originalRow": "Net income", "reprintedRow": "Net income" }, { "pct": 0, "delta": 0, "field": "epsDiluted", "revised": false, "original": 7.46, "realigned": false, "reprinted": 7.46, "originalRow": "Diluted", "reprintedRow": "Diluted" }, { "pct": 0, "delta": 0, "field": "cash", "revised": false, "original": 35934000000, "realigned": false, "reprinted": 35934000000, "originalRow": "Cash and cash equivalents", "reprintedRow": "Cash and cash equivalents" }, { "pct": 0, "delta": 0, "field": "totalAssets", "revised": false, "original": 359241000000, "realigned": false, "reprinted": 359241000000, "originalRow": "Total assets", "reprintedRow": "Total assets" }, { "pct": 0, "delta": 0, "field": "totalLiabilities", "revised": false, "original": 285508000000, "realigned": false, "reprinted": 285508000000, "originalRow": "Total liabilities", "reprintedRow": "Total liabilities" }, { "pct": 0, "delta": 0, "field": "totalEquity", "revised": false, "original": 73733000000, "realigned": false, "reprinted": 73733000000, "originalRow": "Total shareholders’ equity", "reprintedRow": "Total shareholders’ equity" }, { "pct": 0, "delta": 0, "field": "operatingCashFlow", "revised": false, "original": 111482000000, "realigned": false, "reprinted": 111482000000, "originalRow": "Cash generated by operating activities", "reprintedRow": "Cash generated by operating activities" }, { "pct": 0, "delta": 0, "field": "investingCashFlow", "revised": false, "original": 15195000000, "realigned": false, "reprinted": 15195000000, "originalRow": "Cash generated by investing activities", "reprintedRow": "Cash generated by/(used in) investing activities" }, { "pct": 0, "delta": 0, "field": "financingCashFlow", "revised": false, "original": -120686000000, "realigned": false, "reprinted": -120686000000, "originalRow": "Cash used in financing activities", "reprintedRow": "Cash used in financing activities" } ]
Income statement
table #14 · current period is figure column 1| 0 | Years Ended | |||
| 1 | September 26,2026 | September 27,2025 | September 28,2024 | |
| 2 | Net sales: | |||
| 3 | Products | 355,533 | 307,003 | 294,866 |
| 4 | Services | 123,301 | 109,158 | 96,169 |
| 5 | Total net sales← Total revenue | 478,834 | 416,161 | 391,035 |
| 6 | Cost of sales: | |||
| 7 | Products | 215,874 | 194,116 | 185,233 |
| 8 | Services | 29,358 | 26,844 | 25,119 |
| 9 | Total cost of sales | 245,232 | 220,960 | 210,352 |
| 10 | Gross margin | 233,602 | 195,201 | 180,683 |
| 11 | Operating expenses: | |||
| 12 | Research and development | 45,765 | 34,550 | 31,370 |
| 13 | Selling, general and administrative | 29,774 | 27,601 | 26,097 |
| 14 | Total operating expenses | 75,539 | 62,151 | 57,467 |
| 15 | Operating income← Operating income | 158,063 | 133,050 | 123,216 |
| 16 | Other income/(expense), net | 1,174 | (321) | 269 |
| 17 | Income before provision for income taxes | 159,237 | 132,729 | 123,485 |
| 18 | Provision for income taxes | 27,062 | 20,719 | 29,749 |
| 19 | Net income← Net income attributable to the company | 132,175 | 112,010 | 93,736 |
| 20 | Earnings per share: | |||
| 21 | Basic | 9.01 | 7.49 | 6.11 |
| 22 | Diluted← Diluted EPS | 8.98 | 7.46 | 6.08 |
| 23 | Shares used in computing earnings per share: | |||
| 24 | Basic | 14,661,935 | 14,948,500 | 15,343,783 |
| 25 | Diluted | 14,720,306 | 15,004,697 | 15,408,095 |
Balance sheet
table #16 · current period is figure column 1| 0 | September 26,2026 | September 27,2025 | |
| 1 | ASSETS: | ||
| 2 | Current assets: | ||
| 3 | Cash and cash equivalents← Cash and cash equivalents | 36,305 | 35,934 |
| 4 | Marketable securities | 20,417 | 18,763 |
| 5 | Accounts receivable, net | 43,817 | 39,777 |
| 6 | Vendor non-trade receivables | 39,896 | 33,180 |
| 7 | Inventories | 14,541 | 5,718 |
| 8 | Other current assets | 18,881 | 14,585 |
| 9 | Total current assets | 173,857 | 147,957 |
| 10 | Non-current assets: | ||
| 11 | Marketable securities | 80,213 | 77,723 |
| 12 | Property, plant and equipment, net | 52,084 | 49,834 |
| 13 | Intangible assets, net | 20,278 | 11,093 |
| 14 | Other non-current assets | 78,116 | 72,634 |
| 15 | Total non-current assets | 230,691 | 211,284 |
| 16 | Total assets← Total assets | 404,548 | 359,241 |
| 17 | LIABILITIES AND SHAREHOLDERS’ EQUITY: | ||
| 18 | Current liabilities: | ||
| 19 | Accounts payable | 82,252 | 69,860 |
| 20 | Other current liabilities | 66,124 | 66,387 |
| 21 | Deferred revenue | 9,636 | 9,055 |
| 22 | Commercial paper | 1,997 | 7,979 |
| 23 | Term debt | 9,906 | 12,350 |
| 24 | Total current liabilities | 169,915 | 165,631 |
| 25 | Non-current liabilities: | ||
| 26 | Term debt | 68,208 | 78,328 |
| 27 | Other non-current liabilities | 54,332 | 41,549 |
| 28 | Total non-current liabilities | 122,540 | 119,877 |
| 29 | Total liabilities← Total liabilities | 292,455 | 285,508 |
| 30 | Commitments and contingencies | ||
| 31 | Shareholders’ equity: | ||
| 32 | Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 14,532,259 and 14,773,260 shares issued and outstanding, respectively | 104,815 | 93,568 |
| 33 | Retained earnings/(Accumulated deficit) | 13,700 | (14,264) |
| 34 | Accumulated other comprehensive loss | (6,422) | (5,571) |
| 35 | Total shareholders’ equity← Total shareholders' equity attributable to the company | 112,093 | 73,733 |
| 36 | Total liabilities and shareholders’ equity | 404,548 | 359,241 |
Cash flow statement
table #18 · current period is figure column 1| 0 | Years Ended | |||
| 1 | September 26,2026 | September 27,2025 | September 28,2024 | |
| 2 | Cash, cash equivalents, and restricted cash and cash equivalents, beginning balances | 35,934 | 29,943 | 30,737 |
| 3 | Operating activities: | |||
| 4 | Net income | 132,175 | 112,010 | 93,736 |
| 5 | Adjustments to reconcile net income to cash generated by operating activities: | |||
| 6 | Depreciation and amortization | 13,423 | 11,698 | 11,445 |
| 7 | Share-based compensation expense | 13,789 | 12,863 | 11,688 |
| 8 | Other | 568 | (89) | (2,266) |
| 9 | Changes in operating assets and liabilities: | |||
| 10 | Accounts receivable, net | (3,994) | (6,682) | (3,788) |
| 11 | Vendor non-trade receivables | (6,716) | (347) | (1,356) |
| 12 | Inventories | (8,905) | 1,400 | (1,046) |
| 13 | Other current and non-current assets | (21,117) | (9,197) | (11,731) |
| 14 | Accounts payable | 12,171 | 902 | 6,020 |
| 15 | Other current and non-current liabilities | 13,703 | (11,076) | 15,552 |
| 16 | Cash generated by operating activities← Net cash from operating activities | 145,097 | 111,482 | 118,254 |
| 17 | Investing activities: | |||
| 18 | Purchases of marketable securities | (54,945) | (24,407) | (48,656) |
| 19 | Proceeds from maturities of marketable securities | 34,815 | 40,907 | 51,211 |
| 20 | Proceeds from sales of marketable securities | 14,280 | 12,890 | 11,135 |
| 21 | Payments for acquisition of property, plant and equipment | (9,041) | (12,715) | (9,447) |
| 22 | Other | (2,389) | (1,480) | (1,308) |
| 23 | Cash generated by/(used in) investing activities← Net cash from investing activities | (17,280) | 15,195 | 2,935 |
| 24 | Financing activities: | |||
| 25 | Payments for taxes related to net share settlement of equity awards | (6,793) | (5,960) | (5,441) |
| 26 | Payments for dividends and dividend equivalents | (15,721) | (15,421) | (15,234) |
| 27 | Repurchases of common stock | (86,390) | (90,711) | (94,949) |
| 28 | Proceeds from issuance of term debt, net | - | 4,481 | - |
| 29 | Repayments of term debt | (12,396) | (10,932) | (9,958) |
| 30 | Proceeds from/(Repayments of) commercial paper, net | (5,911) | (2,032) | 3,960 |
| 31 | Other | (235) | (111) | (361) |
| 32 | Cash used in financing activities← Net cash from financing activities | (127,446) | (120,686) | (121,983) |
| 33 | Increase/(Decrease) in cash, cash equivalents, and restricted cash and cash equivalents | 371 | 5,991 | (794) |
| 34 | Cash, cash equivalents, and restricted cash and cash equivalents, ending balances | 36,305 | 35,934 | 29,943 |